Clinical Trial Update: Interest of Indocyanine Green in Neoplastic Prostatic Tissue [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating indocyanine green in neoplastic prostatic tissue has been withdrawn. The trial was sponsored by Centre Hospitalier Universitaire de S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Prostatic Neoplasms | Phase 3 | Status: WITHDRAWN